Table 5.
MDR pattern of bacteria isolated from external ocular infected patients at JUMC eye clinic.
Bacterial isolates | Total | Antibiotic resistance pattern | |||||
---|---|---|---|---|---|---|---|
R0 | R1 | R2 | R3 | R4 | ≥R5 | ||
S. aureus | 29 | 0 (0.0) | 0 (0.0) | 4 (13.8) | 5 (17.2) | 7 (24.1) | 13 (44.8) |
CoNS | 41 | 0 (0.0) | 2 (4.9) | 5 (12.2) | 8 (19.5) | 10 (24.4) | 16 (39.0) |
S. pneumoniae | 13 | 0 (0.0) | 1 (7.7) | 3 (23.1) | 3 (23.1) | 6 (46.2) | 0 (0.0) |
S. pyogenes | 5 | 0 (0.0) | 1 (20.0) | 0 (0.0) | 2 (40.0) | 1 (20.0) | 1 (20.0) |
S. agalactiae | 5 | 1 (20.0) | 1 (20.0) | 1 (20.0) | 1 (20.0) | 0 (0.0) | 1 (20.0) |
S. viridians | 3 | 0 (0.0) | 2 (66.7) | 0 (0.0) | 1 (33.3) | 0 (0.0) | 0 (0.0) |
P. aeruginosa | 10 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 3 (30.0) | 2 (20.0) | 5 (50.0) |
K. pneumoniae | 9 | 1 (11.1) | 1 (11.1) | 1 (11.1) | 4 (44.4) | 2 (22.2) | 0 (0.0) |
P. mirabilis | 5 | 0 (0.0) | 2 (40.0) | 2 (40.0) | 0 (0.0) | 0 (0.0) | 1 (20.0) |
P. vulgaris | 4 | 0 (0.0) | 2 (50.0) | 1 (25.0) | 1 (25.0) | 0 (0.0) | 0 (0.0) |
S. marcescens | 3 | 0 (0.0) | 0 (0.0) | 2 (66.7) | 1 (33.3) | 0 (0.0) | 0 (0.0) |
Citrobacter spp. | 5 | 1 (20.0) | 2 (40.0) | 0 (0.0) | 2 (40.0) | 0 (0.0) | 0 (0.0) |
Enterobacter spp. | 3 | 0 (0.0) | 1 (33.3) | 1 (33.3) | 1 (33.3) | 0 (0.0) | 0 (0.0) |
E. coli | 5 | 0 (0.0) | 1 (20.0) | 1 (20.0) | 1 (20.0) | 1 (20.0) | 1 (20.0) |
H. influenzae | 5 | 1 (20.0) | 2 (40.0) | 1 (20.0) | 1 (20.0) | 0 (0.0) | 0 (0.0) |
N. meningitidis | 2 | 0 (0.0) | 2 (100) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Total | 147 | 4 (2.7) | 20 (13.6) | 22 (15.0) | 34 (23.1) | 29 (19.7) | 38 (25.9) |
CoNS: coagulase-negative staphylococci; Ro: bacterial isolate susceptible to all antimicrobial agents tested; R1: bacterial isolate resistance to 1 antimicrobial agent; R2: bacterial isolate resistance to 2 antimicrobial agents of different classes; R3: bacterial isolate resistance to 3 antimicrobial agents of different classes; R4: bacterial isolate resistance to 4 antimicrobial agents of different classes; ≥R5: bacterial isolate resistance to 5 or more antimicrobial agents of different classes.